Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Next Science Limited
  6. Financials
    NXS   AU0000041329

NEXT SCIENCE LIMITED

(NXS)
  Report
Delayed Australian Stock Exchange  -  02:10 2022-09-30 am EDT
0.7600 AUD   -3.18%
08/26Next Science Secures License for Wound Cleaning Product in Canada
MT
08/25Next Science Limited Announces Health Canada Given Licensing Approval for XPERIENCE
CI
08/24Next Science Limited, H1 2022 Earnings Call, Aug 25, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 238187179105--
Enterprise Value (EV)2 22217217294,495,188,7
P/E ratio -15,2x-15,1x-19,0x-10,9x25,5x9,23x
Yield ------
Capitalization / Revenue 58,7x54,3x20,0x6,42x3,36x2,00x
EV / Revenue 54,6x49,9x19,2x5,76x3,04x1,69x
EV / EBITDA -18,6x-14,9x-19,8x-15,2x18,9x4,61x
Price to Book 12,3x9,87x16,5x8,79x12,0x9,22x
Nbr of stocks (in thousands) 180 710194 201197 974214 790--
Reference price (USD) 1,320,960,900,490,490,49
Announcement Date 02/28/202002/21/202102/22/2022---
1 AUD in Million
2 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 4,063,448,9516,431,352,5
EBITDA1 -11,9-11,5-8,69-6,215,0419,2
Operating profit (EBIT)1 -12,5-12,2-9,48-7,281,3414,6
Operating Margin -308%-354%-106%-44,4%4,27%27,8%
Pre-Tax Profit (EBT)1 -14,4-11,9-9,35-5,005,6026,6
Net income1 -14,4-11,9-9,35-7,281,3410,6
Net margin -353%-346%-104%-44,5%4,27%20,2%
EPS2 -0,09-0,06-0,05-0,040,020,05
Dividend per Share2 ------
Announcement Date 02/28/202002/21/202102/22/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2
Net sales1 3,925,035,4113,2
EBITDA1 --4,92-0,30
Operating profit (EBIT)1 --5,21-6,58-0,20
Operating Margin --104%-122%-1,52%
Pre-Tax Profit (EBT)1 --5,15-6,59-0,20
Net income1 --5,15-6,59-0,20
Net margin --102%-122%-1,52%
EPS ----
Dividend per Share ----
Announcement Date 08/29/202102/22/202208/24/2022-
1 USD in Million
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 16,415,17,0910,810,116,5
Leverage (Debt / EBITDA) 1,38x1,31x0,82x1,74x-2,00x-0,86x
Free Cash Flow1 -12,7-12,1-8,98-9,201,7011,0
ROE (Net Profit / Equities) -145%-62,2%-63,0%--22,9%
Shareholders' equity1 9,8819,114,8--46,4
ROA (Net Profit / Asset) -86,1%-51,4%-50,1%-17,6%16,2%34,2%
Assets1 16,723,218,741,48,2531,0
Book Value Per Share2 0,110,100,050,060,040,05
Cash Flow per Share2 -0,07-0,06-0,04-0,040,010,05
Capex1 0,370,210,722,703,204,29
Capex / Sales 9,23%6,20%8,01%16,5%10,2%8,18%
Announcement Date 02/28/202002/21/202102/22/2022---
1 USD in Million
2 USD
Estimates
Key data
Capitalization (AUD) 163 240 501
Capitalization (USD) 105 167 183
Net sales (USD) 8 947 590
Free-Float 47,2%
Free-Float capitalization (AUD) 77 055 744
Free-Float capitalization (USD) 49 642 923
Avg. Exchange 20 sessions (USD) 45 978
Average Daily Capital Traded 0,03%
EPS & Dividend